Prosecution Insights
Last updated: October 04, 2026

Birchwood Ip- Chk001

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering

10 pending office actions • 10 clients • 10 examiners • 9 art units • 0 of 10 (0%) have an AI response strategy ready • 57 patents granted in the last 365 days

Analysis

Birchwood IP- CHK001 operates in the Biotechnology & Pharmaceuticals field with 498 career applications. The firm has achieved a resolved allowance rate of 94.33 percent. Currently, the firm has 6 pending office actions, which represent its active workload relative to its 498 career applications.

The firm's efficiency is reflected in an average of 1.01 office actions per allowance. This 1.01 average indicates a direct prosecution strategy. For practitioners, the 94.33 percent resolved allowance rate and the 1.01 office actions per allowance metric highlight the firm's performance in the Biotechnology & Pharmaceuticals sector. The 498 career applications provide a history of results, and the 6 pending office actions show the firm's current activity in securing patent grants. The 1.01 office actions per allowance figure suggests that many applications reach resolution with minimal examiner interaction, providing a benchmark for expected prosecution timelines.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=498 apps, methodology: how we score firms)

94.3%
Allowance Rate
n=498
+0.32σ
Allowance Rate (norm)
n=498
1.0
OAs to Allowance
n=399
-1.67σ
OAs to Allow (norm)
n=399
764 days
Time to Allowance
n=399
+5.8pp
Interview Lift
n=498
3.1%
RCE Rate
n=498
0.0%
Appeal Rate
n=498

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=6 (min 20)
71.9%
§102 Overcome
n=57
60.5%
§103 Overcome
n=86
81.9%
§112 Overcome
n=127

Specialization & Scale

E03C, F16K, B65D
Top CPC Subclasses
11%
Top-3 CPC Share
n=498
0
Practitioners
n=498
—
Apps / Practitioner
n=498 (min 20)

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

6
Hard (60%)
4
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (10%)
§103 only3 (30%)
§102 only1 (10%)
Multi-statute (no §101)5 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
30% of docket
1
Business / Other
10% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
COLLIER, JAMESON D 1 54.2% +47.0%
BAKER, LORI LYNN 1 78.5% +6.6%
MCFARLAND, KATHLEEN MAVOURNEEN 1 59.4% +13.2%
GROOMS, NOA WILLIAM FRAN 1 75.0% +0.0%
BETIT, JACOB F 1 33.9% +17.0%
LU, JIONG-PING 1 83.6% +7.8%
GILLETT, JENNIFER ANN 1 29.6% +37.7%
MURESAN, ANA Z 1 75.0% +31.3%
JADHAO, SAMADHAN JAISING 1 46.9% +46.2%
PETRASH, HILARY ANN 1 64.5% +51.7%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18294174 CHEMICAL-MECHANICAL COMBINED MACHINING METHOD FOR SILICON CARBIDE SURFACE LU, JIONG-PING 26d

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17681855 Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof PETRASH, HILARY ANN 19d
18275226 S-RBD Trimer Protein Vaccine for Novel Coronavirus and Preparation Method and Application Therefor JADHAO, SAMADHAN JAISING 47d
19515421 SHOE SOLE WITH GRAPHENE PROPULSION PLATE COLLIER, JAMESON D —
18950225 FOLDABLE PROTECTIVE COVER MCFARLAND, KATHLEEN MAVOURNEEN —
18704949 LUMINESCENT MATERIAL AND MINI-LED DEVICE PREPARED USING LUMINESCENT MATERIAL GROOMS, NOA WILLIAM FRAN —
18288197 SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR GILLETT, JENNIFER ANN —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18434764 BEVERAGE CONTAINER AND COVER UNIT BETIT, JACOB F 324d overdue
17681855 Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof PETRASH, HILARY ANN 19d
18275226 S-RBD Trimer Protein Vaccine for Novel Coronavirus and Preparation Method and Application Therefor JADHAO, SAMADHAN JAISING 47d
19515421 SHOE SOLE WITH GRAPHENE PROPULSION PLATE COLLIER, JAMESON D —
18950225 FOLDABLE PROTECTIVE COVER MCFARLAND, KATHLEEN MAVOURNEEN —
18288197 SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR GILLETT, JENNIFER ANN —
17610458 KETTLE-TYPE CONTINUOUS PRODUCTION METHOD FOR GLYCINE MURESAN, ANA Z —

Client Portfolio (10 clients)

Top Art Units

Art UnitApps
37321
37541
17341
37351
17131
17891
16921
16721
16441

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19515421 SHOE SOLE WITH GRAPHENE PROPULSION PLATE Xtep (China) Co., Ltd. COLLIER, JAMESON D 3732 §102§103§112 Non-Final OA — Pending Feb 27, 2026
19055564 WATER SINK Xiamen Boma International Trade Co., Ltd. BAKER, LORI LYNN 3754 §103 Non-Final OA — Pending Feb 18, 2025
18950225 FOLDABLE PROTECTIVE COVER Xiamen Yixin Trading Co., Ltd. MCFARLAND, KATHLEEN MAVOURNEEN §103§112 Non-Final OA — Pending Nov 18, 2024
18704949 LUMINESCENT MATERIAL AND MINI-LED DEVICE PREPARED USING LUMINESCENT MATERIAL Xiamen University GROOMS, NOA WILLIAM FRAN 1734 §103§112 Non-Final OA — Pending Apr 26, 2024
18434764 BEVERAGE CONTAINER AND COVER UNIT Zhejiang Hasa Science&Technology Co., Ltd. BETIT, JACOB F 3735 §102 Non-Final OA 324d overdue Pending Feb 06, 2024
18294174 CHEMICAL-MECHANICAL COMBINED MACHINING METHOD FOR SILICON CARBIDE SURFACE Huaqiao University LU, JIONG-PING 1713 §103 Non-Final OA 26d Pending Feb 01, 2024
18288197 SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR Xiamen Yanjan New Material Co., Ltd. GILLETT, JENNIFER ANN 1789 §103§112 Final Rejection — Pending Oct 25, 2023
17610458 KETTLE-TYPE CONTINUOUS PRODUCTION METHOD FOR GLYCINE Huayang New Material Technology Group Co., Lt MURESAN, ANA Z 1692 §103 Non-Final OA — Pending Sep 12, 2023
18275226 S-RBD Trimer Protein Vaccine for Novel Coronavirus and Preparation Method and Application Therefor National Vaccine And Serum Institute (Nvsl) JADHAO, SAMADHAN JAISING 1672 §101§103§112 Final Rejection 47d Pending Aug 01, 2023
17681855 Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof Institute Of Hematology And Blood Diseases Hospital, Chinese Academy Of Medical Sciences PETRASH, HILARY ANN 1644 §103§112Other Final Rejection 19d Pending Feb 28, 2022

Managing Birchwood Ip- Chk001's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month